Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1248269.RApoYXnCzU71AbrtBeMt-opl4Pqu9jpIv2A_P9Gc7eiAc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1248269.RApoYXnCzU71AbrtBeMt-opl4Pqu9jpIv2A_P9Gc7eiAc130_assertion type Assertion NP1248269.RApoYXnCzU71AbrtBeMt-opl4Pqu9jpIv2A_P9Gc7eiAc130_head.
- NP1248269.RApoYXnCzU71AbrtBeMt-opl4Pqu9jpIv2A_P9Gc7eiAc130_assertion description "[The combination of gefitinib with calcitriol or their synthetic analogs resulted in a greater antiproliferative effect than with either of the agents alone in EGFR and HER2 positive breast cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1248269.RApoYXnCzU71AbrtBeMt-opl4Pqu9jpIv2A_P9Gc7eiAc130_provenance.
- NP1248269.RApoYXnCzU71AbrtBeMt-opl4Pqu9jpIv2A_P9Gc7eiAc130_assertion evidence source_evidence_literature NP1248269.RApoYXnCzU71AbrtBeMt-opl4Pqu9jpIv2A_P9Gc7eiAc130_provenance.
- NP1248269.RApoYXnCzU71AbrtBeMt-opl4Pqu9jpIv2A_P9Gc7eiAc130_assertion SIO_000772 25510900 NP1248269.RApoYXnCzU71AbrtBeMt-opl4Pqu9jpIv2A_P9Gc7eiAc130_provenance.
- NP1248269.RApoYXnCzU71AbrtBeMt-opl4Pqu9jpIv2A_P9Gc7eiAc130_assertion wasDerivedFrom befree-2016 NP1248269.RApoYXnCzU71AbrtBeMt-opl4Pqu9jpIv2A_P9Gc7eiAc130_provenance.
- NP1248269.RApoYXnCzU71AbrtBeMt-opl4Pqu9jpIv2A_P9Gc7eiAc130_assertion wasGeneratedBy ECO_0000203 NP1248269.RApoYXnCzU71AbrtBeMt-opl4Pqu9jpIv2A_P9Gc7eiAc130_provenance.